Skip to main content
SpringerLink
Log in

Progressive Macular Hypomelanosis

An Overview

  • Review Article
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Progressive macular hypomelanosis (PMH) is a common skin disorder that is often misdiagnosed. Various authors have written about similar skin disorders, referring to them by different names, but we believe that all these similar disorders are part of the same entity.

PMH is characterized by ill-defined nummular, non-scaly hypopigmented spots on the trunk, often confluent in and around the midline, and rarely extending to the proximal extremities and neck/head region. There is no itch, pain, or preceding inflammation. PMH has a worldwide distribution; however, it is more often identified in Black people living in or originating from tropical countries. It is also more often seen in young females. The natural history of PMH is stable disease or perhaps slow progression over decades, with spontaneous disappearance after mid-life. Extensive pityriasis alba is probably identical with PMH and we suggest discontinuation of use of the former term on the grounds that extensive pityriasis alba is histologically and clinically different from classical pityriasis alba, which is basically an eczematous type of disorder.

PMH is characterized histologically by diminished pigment in the epidermis and a normal-looking dermis.Electron microscopy shows a shift from large melanosomes in normal-looking skin to small aggregated,membrane-bound melanosomes in hypopigmented skin. PMH should be differentiated from other disorders with hypopigmentation on the trunk such as pityriasis versicolor.

We propose that Propionibacterium acnes bacteria living in hair follicles are the cause of PMH as a result of production of a hypothetical depigmenting factor. This hypothesis is based on: (i) the presence of a red follicular fluorescence in the hypopigmented spots and the absence of this phenomenon in normal skin when examined under a Wood’s light in a dark room; (ii) cultivation of P. acnes from the follicles in the hypopigmented spots but not from follicles in normal-looking skin; and (iii) improvement of the disorder after elimination of these micro-organisms with topical antimicrobial treatment in combination with UVA light.

Currently, the treatment of choice of PMH is application of 1% clindamycin lotion during the daytime, 5% benzoyl peroxide gel at night-time, and UVA light irradiation three times a week for a period of 12 weeks. There is insufficient information available as yet to comment on the recurrence rate after therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Table I
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Guillet G, Gauthier Y, Helenon R.: Hypoméelanose maculaire progressive du tronc (hypopigmentation primitive acquise des Antilles). Soc Fr Dermatol (Paris) 1985 Mar

    Google Scholar 

  2. Guillet G, Helenon R, Gauthier Y.: Progressive macular hypomelanosis of the trunk: primary acquired hypopigmentation. J Cutan Pathol 1988; 15: 286–9

    Article  PubMed  CAS  Google Scholar 

  3. Guillet G, Helenon R, Guillet MH.: Hypomelanose maculeuse confluente et progressive du metis melanoderme. Ann Dermatol Venereol 1992; 119(1): 19–24

    PubMed  CAS  Google Scholar 

  4. Menke HE, Doornweerd S, Zaal J.: Acquired nummular and confluent hypomelanosis of the trunk. Paper presented at the Second Annual Meeting of the European Society for Pigment Cell Research; 1989 June 18–21; Uppsala

    Google Scholar 

  5. Menke HE, Ossekoppele R, Dekker SK.: deNummulaire en confluerende hypomelanosis van de romp. Ned Tijdsch Dermatol Venereol 1997; 7: 117–22

    Google Scholar 

  6. Menke HE, Relyveld G, Njoo D,.: Progressive macular hypomelanosis. In: Nordlund JJ, Boissy RE, Hearing VJ.; editors. The pigmentary system. 2nd ed. Malden (MA): Blackwell Publishing, 2006: 748–51

    Google Scholar 

  7. Borelli D.: deCutis trunci variata: nueva genodermatosis. Med Cutanea Ibero Lat Am 1987; 15: 317–9

    CAS  Google Scholar 

  8. Lesueur A, Garcia-Granel V, Helenon R.: deHypomélanose maculeuse confluente et progressive du métis méelanoderme: etude epidemiologique sur 511 subjets. Ann Dermatol Venereol 1994; 121: 880–3

    PubMed  CAS  Google Scholar 

  9. Fitzpatrick TB. In. Sober AJ, Fitzpatrick TB, editors.: Yearbook of dermatology. St Louis (MO): Mosby-Year Book, 1996: 416–7

    Google Scholar 

  10. Di Lernia V, Ricci C.: Progressive and extensive hypomelanosis and extensive pityriasis alba: same disease, different names? JEADV 2005; 19: 370–2

    PubMed  Google Scholar 

  11. Zaynoun ST, Aftimos BG, Tenekjian KK.: Extensive pityriasis alba: a histological histochemical and ultrastructural study. Br J Dermatol 1983; 108(1): 83–90

    Article  PubMed  CAS  Google Scholar 

  12. Zaynoun ST, Abi Ali Jaber L, Kurban AK. Oral methoxsalen photochemotherapy of extensive pityriasis alba. J Am Acad Dermatol1986;15:61–5

    Article  PubMed  CAS  Google Scholar 

  13. Relyveld G, Menke H, Westerhof W.: tLetter to the editor: progressive and extensive hypomelanosis and extensive pityriasis alba: same disease, different names? J Eur Acad Dermatol Venereol 2006; 20(10): 1363–4

    Article  PubMed  CAS  Google Scholar 

  14. Westerhof W, Relyveld GN, Kingswijk M.: Propionibacterium acnes and the pathogenesis of progressive macular hypomelanosis. Arch Dermatol 2004; 140: 210–4

    Article  PubMed  Google Scholar 

  15. Westerhof W.: A possible dysfunction of melanosome transfer in leprosy: an electron-microscopic study. Acta Derm Venereol 1977; 57: 297–304

    PubMed  CAS  Google Scholar 

  16. Kumarasinghe SP, Tan SH, Thng S.: Progressive macular hypomelanosis in Singapore: a clinico-pathological study. Int J Dermatol 2006; 45(6): 737–42

    Article  PubMed  Google Scholar 

  17. Relyveld GN, Kingswijk M, Reitsma JB.: Benzoyl peroxide/clindamycin/ultraviolet A is more effective than fluticasone/ultraviolet A in progressive macular hypomelanosis: a randomized study. J Am Acad Dermatol 2006; 55(5): 836–43

    Article  Google Scholar 

Download references

Acknowledgments

No sources of funding were used to assist in the preparation of this review. The authors have no conflicts of interest that are directly relevant to the content of this review.

Author information

Authors and Affiliations

  1. The Netherlands Institute for Pigment Disorders, Academic Medical Center, University of Amsterdam, Meibergdreef 35, Amsterdam, 1105 AZ, The Netherlands

    Germaine N. Relyveld &  Wiete Westerhof

  2. Department of Dermatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

    Germaine N. Relyveld

  3. Department of Dermatology, Sint Franciscus Gasthuis, Rotterdam, The Netherlands

    Henk E. Menke

Authors
  1. Germaine N. Relyveld
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Henk E. Menke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wiete Westerhof
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wiete Westerhof.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Relyveld, G.N., Menke, H.E. & Westerhof, W. Progressive Macular Hypomelanosis. Am J Clin Dermatol 8, 13–19 (2007). https://doi.org/10.2165/00128071-200708010-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128071-200708010-00002

Keywords

Search

Navigation